Latest Women’s Health News
If you are looking for information, tips, and answers to women’s health questions, you have come to the right place. As a program of the Cleveland Clinic Center for Specialized Women’s Health, we can offer you expert advice and current articles from the women’s health community about maturing women related health topics, including:
- Dietary concerns
- Menopause management
- Necessary medical tests
- Osteoporosis prevention
You’ll also find cutting edge women’s health news from the Cleveland Clinic, as well as developments from other women’s health news outlets all within the Speaking of Women’s Health community section.
Make sure to stay up-to-date on current women’s health news, articles and videos by viewing the releases below.
July 2018 -- Indiana patient describes her positive experiences using the Cleveland Clinic Express Care Online app for virtual appointments with Dr. Holly L. Thacker.Read more…
July 2018 -- Many women recognize subtle signs that their period is about to start. An uptick in chocolate cravings, unexplained crankiness and fatigue are common symptoms of premenstrual syndrome (PMS) that typically come and go relatively quickly. But for others, these symptoms are anything but subtle.
A small percentage of women (3%-9%) have premenstrual dysphoric disorder (PMDD), a medical condition that causes intense physical and emotional symptoms beginning up to two weeks before menstruation starts. Dr. Holly L. Thacker discusses how physicians diagnose PMDD through symptom tracking.Read more…
June 2018 -- Pharmacy benefit managers, or PBMs, are supposed to help control costs for payers and lower out-of-pocket costs for plan members. But as a team of investigative journalists with the Columbus Dispatch are revealing, some pharmacy benefit managers are skimming hundreds of millions of dollars in Ohio alone, boosting drug costs for everyone.
Pharmacy benefit managers market themselves as keen negotiators able to squeeze pharmaceutical manufacturers for better deals that save money for insurers, patients, and society. Yet they are turning out to be little more than middlemen, adding scant value but significantly increasing costs. They have no fiduciary responsibility to their customers.Read more…
June 2018 -- The first drug developed specifically to reduce excessive sweating, a common condition that can cause people anxiety and affect their social lives, has been approved.
The Food and Drug Administration approved Qbrexza for excessive underarm sweating and will be available in October 2018. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.Read more…
May 2018 -- The American Cancer Society, responding to a rise in colorectal cancer rates among younger people, is now recommending that adults undergo screening for the disease beginning at age 45 rather than 50.
The organization, which announced the change in its guidelines Wednesday, said extensive analysis showed that lowering the starting age for screening would save lives. The recommendations apply to adults who are at average risk of the disease; this includes most people in the United States.Read more…
May 2018 -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY™ (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause.Read more…
May 2018 -- The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults.Read more…
April 2018 -- Clinicians should target a regimen for birth control that is simple and medically appropriate to help cut down on the significant rate of unintended pregnancies, Pelin Batur, MD, NCMP, CCD, education director in primary care women’s health at the Cleveland Clinic, told Healio Family Medicine. “With all contraceptives, when you put human error into it, the effectiveness goes down,” Batur said.
Another step practices can take to improve use of contraception is to recognize that screening for conditions such as sexually transmitted infections, breast cancer and cervical cancer, while important, are not prerequisites for starting contraception and could be a barrier to treatment, she said.Read more…
New study evaluates effect of menopause and depression on vascular function.Read more…
March 2018 -- Menopause can have a substantial impact on a woman's bone density and risk for osteoporosis, but there is no one-size-fits-all strategy for dealing with the issue. Dr. Holly L. Thacker and other women health experts weigh in on when, how to prevent osteoporosis in midlife women.Read more…